LAPPE MARK (Chief Executive Officer) purchased 6.0% of their position (40K shares) of INHIBRX BIOSCIENCES, INC. on the open market
Open‑market purchase worth $629.1K — a moderate purchase. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 9/16/2024ACC: 0002007919-24-000049
DirectorOfficer· Chief Executive Officer
Since May 2024
+40K
Net shares
Net buyer
$629.1K
Total acquired
2
Open market trades
2B · 0S
2
Total transactions
40K acquired
Non-Derivative Transactions2
Common Stock
Indirect
Shares
+26.96K
Price / share
$15.05
Trade value
$405.79K
% of position
4.1%
9/12/2024
665.55K→692.51K
Common Stock
Indirect
Shares
+13.04K
Price / share
$17.13
Trade value
$223.32K
% of position
1.9%
9/16/2024
692.51K→705.55K
Total
Net shares
+40K
Net value
$629.12K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 9/12/2024 | P · Purchase | +26.96K | $15.05 | $405.79K | 4.1% | 665.55K | 692.51K |
| Common Stock Indirect | 9/16/2024 | P · Purchase | +13.04K | $17.13 | $223.32K | 1.9% | 692.51K | 705.55K |
| Total | +40K | $629.12K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Common Stock
IndirectShares owned54.87K
Common Stock
IndirectShares owned165K
Total
219.87K indirect219.87K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 54.87K | Indirect |
| Common Stock | 165K | Indirect |
| Total | 219.87K | 219.87K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported